Vivienne I. Rebel

EVP, Chief Sci. & Med. Officer, bioAffinity Technologies, Inc.

Companies

bioAffinity Technologies, Inc.EVP, Chief Sci. & Med. Officer Nov 22, 2022 to Feb 2, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

bioAffinity Technologies, Inc. BIAF46,228 shares²$165.0K at $3.57Jan 31, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Jan 31, 2024Granted 31,847 shares of bioAffinity Technologies, Inc.²
Nov 17, 2022Granted 7,239 shares of bioAffinity Technologies, Inc.³

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARbioAffinity Technologies, Inc., EVP, Chief Sci. & Med. Officer
2
SEC EDGARbioAffinity Technologies, Inc. shares after the filing of Jan 31, 2024
3
SEC EDGARForm 4 filed Nov 22, 2022